Chisholm S A, Neal T J, Alawattegama A B, Birley H D L, Howe R A, Ison C A
Sexually Transmitted Bacteria Reference Laboratory, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, Colindale, London NW9 5HT, UK.
J Antimicrob Chemother. 2009 Aug;64(2):353-8. doi: 10.1093/jac/dkp188. Epub 2009 May 25.
This study aimed to investigate the origin of high-level azithromycin resistance that emerged in isolates of Neisseria gonorrhoeae in England and Wales in 2007, and to establish methods for identifying high-level azithromycin resistance.
The Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) data from 2001-07 were examined for emerging trends in azithromycin susceptibility. Further to the identification of six high-level azithromycin-resistant isolates in GRASP 2007, an additional 102 isolates were selected on the basis of azithromycin susceptibility and geographic origin from the GRASP 2006 and 2007 collections. Susceptibility testing by Etest and disc diffusion was performed on all 108 isolates and 75 of these were typed by N. gonorrhoeae multiantigen sequence typing.
A slight drift towards higher MICs of azithromycin was observed in the gonococcal population since 2001. Of greater concern was the first example of a shift to high-level resistance observed in six isolates in 2007. All six isolates were sequence type 649, which was not observed in any of the lower-level azithromycin-resistant isolates from 2007 or in any isolates tested from the same geographical locations. Contact tracing data for one patient suggested a link with Scotland. Disc diffusion testing of all 108 isolates showed that azithromycin, but not erythromycin, discs can differentiate between low-level and high-level resistance.
High-level azithromycin resistance has emerged in England and Wales. Contact tracing and typing data suggest this may have originated from Scotland. Surveillance of azithromycin resistance will be key in controlling its further dissemination.
本研究旨在调查2007年在英格兰和威尔士淋病奈瑟菌分离株中出现的高水平阿奇霉素耐药性的起源,并建立鉴定高水平阿奇霉素耐药性的方法。
检查2001 - 2007年淋病奈瑟菌对抗菌药物监测计划(GRASP)的数据,以了解阿奇霉素敏感性的新趋势。除了在2007年GRASP中鉴定出6株高水平阿奇霉素耐药分离株外,还根据阿奇霉素敏感性和地理来源,从2006年和2007年GRASP收集的菌株中另外选择了102株分离株。对所有108株分离株进行了Etest和纸片扩散法药敏试验,其中75株通过淋病奈瑟菌多抗原序列分型进行分型。
自2001年以来,在淋病奈瑟菌群体中观察到阿奇霉素的最低抑菌浓度(MIC)有轻微上升趋势。更令人担忧的是2007年在6株分离株中首次出现向高水平耐药性的转变。所有6株分离株均为序列型649,在2007年任何低水平阿奇霉素耐药分离株或来自相同地理位置的任何测试分离株中均未观察到。一名患者的接触者追踪数据表明与苏格兰有关联。对所有108株分离株的纸片扩散试验表明,阿奇霉素纸片而非红霉素纸片可区分低水平和高水平耐药性。
在英格兰和威尔士已出现高水平阿奇霉素耐药性。接触者追踪和分型数据表明,这可能起源于苏格兰。对阿奇霉素耐药性的监测将是控制其进一步传播的关键。